ATCH vs HIVE
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 27, 2026
ATCH
44.1
AI Score
VS
ATCH Wins
HIVE
37.0
AI Score
Investment Advisor Scores
HIVE
37score
Recommendation
SELL
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | ATCH | HIVE | Winner |
|---|---|---|---|
| Revenue | 13.51M | 79.12M | HIVE |
| Net Income | 4.41M | -142.91M | ATCH |
| Net Margin | 32.7% | -180.6% | ATCH |
| ROE | 19.8% | -33.8% | ATCH |
| ROA | 6.0% | -15.5% | ATCH |
| Total Assets | 73.92M | 924.64M | HIVE |
| Cash | 16.71M | 208.04M | HIVE |
| Current Ratio | 1.52 | 1.96 | HIVE |
Relative Price Performance (Last 90 Days)
ATCH 1M: -0.3%
· 3M: -0.5%
HIVE 1M: +9.4%
· 3M: -12.0%
Current Technical Phase
ATCH
DistributionTrim / tighten stop
Price near a flattening SMA50 (slope -0.3%) with fading momentum, RSI 49
HIVE
DistributionTrim / tighten stop
Price near a flattening SMA50 (slope -2.6%) with fading momentum, RSI 46
Fundamentals Snapshot
| Metric | ATCH | HIVE |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -3.1 | -5.8 |
| Trailing P/E | 10.1 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 1.4% | 0.7% |
| Gross Margin | 0.7% | 0.4% |
| Operating Margin | -0.4% | -0.6% |
| EPS | 0.02 | -1.39 |
| Dividend Yield | — | — |
Frequently Asked Questions
Based on our detailed analysis, ATCH is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.